MAM
MPM Asset Management Portfolio holdings
AUM
$43.3M
This Quarter Return
+3.58%
1 Year Return
-54.44%
3 Year Return
+14.05%
5 Year Return
-29.8%
10 Year Return
-11.6%
AUM
$182M
AUM Growth
+$182M
(-26%)
Cap. Flow
-$66.7M
Cap. Flow
% of AUM
-36.63%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Dyne Therapeutics
DYN
|
$66.7M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Entrada Therapeutics
TRDA
$208M
| $63.1M | 34.64% | 4,425,784 | – | – |
|
|
2
Dyne Therapeutics
DYN
$1.92B
| $55.1M | 30.26% | 1,561,496 -1,889,807 | -55% | -$66.7M |
|
3
iTeos Therapeutics
ITOS
| $40.6M | 22.32% | 2,738,785 | – | – |
|
4
Werewolf Therapeutics
HOWL
$59.9M
| $10.5M | 5.74% | 4,284,172 | – | – |
|
5
Repare Therapeutics
RPTX
$71.7M
| $7.4M | 4.06% | 2,242,636 | – | – |
|
|
ADAP
6
Adaptimmune Therapeutics
ADAP
$15.6M
| $5.42M | 2.97% | 5,555,461 | – | – |
|